Bhopal Methyl Isocyanate Affected Population and Cancer Susceptibility: Where Do We Stand Now?

Bhopal methyl isocyanate affected population and cancer susceptibility: where do we stand now?

Further to our recent publications on cancer morbidity of Methyl isocyanate (MIC) exposed long-term survivors and their offspring and carcinogenesis of MIC in this journal (Senthilkumar et al., 2011; 2012), my attention was drawn to express my views to Indian Council of Medical Research (ICMR) for the need to validate MIC in cancer etiology, in particular, to cancer risk prediction in the prese...

Adhesive small bowel obstruction: where do we stand now?

Adhesive small bowel obstruction (ASBO) is one of the most frequently encountered disorders in Emergency Surgery Departments worldwide without negligible hospital admission rates and social costs (1,2). Notwithstanding significant improvements in techniques and materials, intra-abdominal adhesions following abdominal surgery still represent a major unsolved and debated issue harbouring challeng...

The Battle Against COVID-19: Where Do We Stand Now?

The toxicity of methyl isocyanate: Where do we stand?

Background: The extent to which clinical and non-clinical factors impact on the waiting-list prioritization preferences of patients in the queue is unknown. Using a series of hypothetical scenarios, the objective of this study was to examine the extent to which clinical and non-clinical factors impacted on how patients would prioritize others relative to themselves in the coronary artery bypass...

Angiogenesis: where do we stand now?

Angiogenesis : Where Do We Stand Now? Print ISSN: 0009-7322. Online ISSN: 1524-4539 Copyright © 2005 American Heart Association, Inc. All rights reserved. is published by the American Heart Association, 7272 Greenville Avenue, Dallas, TX 75231 Circulation doi: 10.1161/01.CIR.0000159345.00591.8F 2005;111:1556-1566 Circulation. http://circ.ahajournals.org/content/111/12/1556 World Wide Web at: Th...